Full Papers
Investigation of different genomic variants in familial Mediterranean fever cases with monoallelic MEFV mutation
M. Kocabey1, T. Cankaya2, M.T. Bayram3, A. Ulgenalp4, A.O. Caglayan5, O. Giray Bozkaya6
- Department of Medical Genetics, Dokuz Eylul University Faculty of Medicine, Balcova, Izmir, Turkey. mehmet_kocabey@hotmail.com
- Department of Medical Genetics, Dokuz Eylul University Faculty of Medicine, Balcova, Izmir, Turkey
- Department of Paediatric Nephrology, Dokuz Eylul University Faculty of Medicine, Balcova, Izmir, Turkey.
- Department of Medical Genetics, Dokuz Eylul University Faculty of Medicine, Balcova, Izmir, Turkey.
- Department of Medical Genetics, Dokuz Eylul University Faculty of Medicine, Balcova, Izmir, Turkey.
- Department of Paediatric Genetics, Dokuz Eylul University Faculty of Medicine, Balcova, Izmir, Turkey.
CER16348
2023 Vol.41, N°10
PI 2017, PF 2026
Full Papers
Free to view
(click on article PDF icon to read the article)
PMID: 37140617 [PubMed]
Received: 08/11/2022
Accepted : 27/01/2023
In Press: 28/04/2023
Published: 30/10/2023
Abstract
OBJECTIVES:
Familial Mediterranean Fever (FMF) is an inflammatory disease characterised by periodic fever and concurrent episodes of serous membrane inflammation. FMF is considered to be inherited in autosomal recessive manner and biallelic mutations in the MEFV gene are associated with the disease. However, approximately 20-25% of patients only have a single mutation in MEFV gene, which creates confusion in differential diagnosis of many patients. This study aimed to reveal rare variants that may act in conjunction with the single pathogenic MEFV variant in the pathogenesis of FMF.
METHODS:
We performed whole exome sequencing in 17 individuals from 5 different families who were diagnosed according to the clinical criteria, responded positively to colchicine treatment, but had no biallelic MEFV mutation.
RESULTS:
A disease-causing variant or a common affected cellular pathway that was shared in all index cases was not detected. When cases were examined individually, two de novo variants were identified in the BIRC2 and BCL10 genes, both of which play a role in inflammatory pathways. Functional studies are needed to confirm the physiopathological relationship of these genes with FMF.
CONCLUSIONS:
This study is one of the most extensive aetiological researches in FMF cases with monoallelic MEFV mutation. We have shown that genotype-phenotype correlation in these cases may not be established by rare genetic variants and discussed underlying causes. Clinical criteria with emphasis on colchicine response and family history should be the main tool and genetic results should only be used for support in FMF diagnosis.
